4//SEC Filing
Campbell James H 4
Accession 0001567619-22-006588
CIK 0000722723other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 7:11 PM ET
Size
8.2 KB
Accession
0001567619-22-006588
Insider Transaction Report
Form 4
HANGER, INC.HNGR
Campbell James H
SVP, Chief Clinical Officer
Transactions
- Award
Common Stock
2022-03-07+6,283→ 53,174 total - Sale
Common Stock
2022-03-08$19.52/sh−4,000$78,082→ 49,174 total
Holdings
- 27,328
Stock Options (right to buy)
Exercise: $12.77Exp: 2027-05-19→ Common Stock (27,328 underlying)
Footnotes (2)
- [F1]Represents a grant of time-based restricted stock under the Company's 2019 Omnibus Incentive Plan ("Plan"), which vests to the extent of 25% annually beginning on the first anniversary date of the grant and cumulatively vests to the extent of 25% each year thereafter. The restricted stock being reported does not include the contingent right of the reporting person to receive up to 6,283 additional performance shares under the Plan based on the achievement of certain performance targets for the fiscal year 2022.
- [F2]Stock options were granted under the Company's Special Equity Plan and vested 1/3 on each of May 19, 2018, 2019 and 2020.
Documents
Issuer
HANGER, INC.
CIK 0000722723
Entity typeother
Related Parties
1- filerCIK 0001757390
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 7:11 PM ET
- Size
- 8.2 KB